Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-201-8 | CAS number: 79-38-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
As the test substance is a gas at room temperature, studies through oral and dermal routes are not feasible.
Several studies (K2 or K4) through the inhalation route are available, performed on several species (rat, mouse, guinea pig, rabbit, dog).The key study (Waltheret al.,1970) for this endpoint was selected between the studies having K2 reliability and covering the range of exposure concentrations suitable for classification according to EU GHS criteria.
CTFE is classified as Acute Toxicity by Inhalation Category 3 based on the LC50 (4h, mouse) > 1000 ppm; < 3000 ppm.
Kidney appears to be the target organ of CTFE, and nephrotoxicity has been observed to be the main cause of the observed lethality. The effects observed on kidney at not lethal concentration are consistent with the effects observed at higher concentration which leaded mortality.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Groups of mice were exposed to air containing CTFE in concentrations of 1000, 3000 and 8000 ppm for several exposure durations.
- GLP compliance:
- no
- Test type:
- concentration x time method
- Limit test:
- no
- Specific details on test material used for the study:
- Purity = 99.59%
Gas chromatografic analysis showed six-unspecified contaminats. - Species:
- mouse
- Strain:
- not specified
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- no data
- Route of administration:
- inhalation: gas
- Type of inhalation exposure:
- not specified
- Vehicle:
- air
- Details on inhalation exposure:
- Groups of mice were exposed to 60 liters of air.
99.59% pure CTFE in concentrations of 0.1%, 0.3% and 0.8% was added to the air immediately before the air entered the inhalation chamber.
Throughout the experiment the air-CTFE mixture was changed twice every hour in order to maintain a constant concentration. - Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- Gas-chromatographic analysis
- Duration of exposure:
- >= 1 - <= 36 h
- Remarks on duration:
- C = 0.1 %(v/v) (4 groups) --> exp duration: 12, 16, 24 or 36 hours. C = 0.3 %(v/v) (4 groups) --> exp duration: 2.5, 4, 7 or 16 hours. C = 0.8 %(v/v) (5 groups) --> exp duration:: 1, 1.5, 2, 3 or 4,25 hours.
- Concentrations:
- 0.1%, 0.3%, 0.8% (v/v)
- No. of animals per sex per dose:
- Not more than 20 mice / group
- Control animals:
- not specified
- Details on study design:
- Gropus of mice (<= 20 mice/group) were exposed to a mixute of air-CTFE in concentrations of 0.1, 0.3 and 0.8%.(v/v) CTFE for several exposure durations:
C = 0.1 %(v/v) (4 groups) --> exp duration: 12, 16, 24 or 36 hours.
C = 0.3 %(v/v) (4 groups) --> exp duration: 2.5, 4, 7 or 16 hours.
C = 0.8 %(v/v) (5 groups) --> exp duration:: 1, 1.5, 2, 3 or 4,25 hours.
Biochemical, optical, electro-microscopic studies and enzyme-histochemical examinations, especially on the liver and kidneys were carried out in order to establish the different phases of the toxic sequence. - Statistics:
- no data
- Key result
- Sex:
- male
- Dose descriptor:
- LC50
- Effect level:
- > 1 000 - < 3 000 ppm
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Remarks on result:
- other:
- Remarks:
- based on the complete set of lethality data
- Key result
- Sex:
- male
- Dose descriptor:
- LC50
- Effect level:
- 2 430 ppm
- Based on:
- test mat.
- 95% CL:
- > 2 257 - < 2 576
- Exp. duration:
- 4 h
- Remarks on result:
- other:
- Remarks:
- Calculated by LogProbit analysis based on the complete set of lethality data
- Mortality:
- At concentration of 0.1% (v/v): 40%, 60%, 100%, 100% lethality occurred at 12h, 16h, 24h and 36h exposure.
At concentration of 0.3% (v/v) : 30%, 85%, 100%, 100% lethality occurred at 2.5h, 4h, 7h and 16h exposure.
At concentration of 0.8%(v/v): 75%, 100%,100%, 100%, 100% occurred at 1h, 1.5h, 2h, 3h and 4.25h exposure.
Following exposure to CTFE at the concentration at or above 0.3% (v/v) and an exposure time of 2 hours, the animals die very promptly.
At the concentration of 0.8% which produces only 10% immediate lethality after 2 hours exposure, all animals succumbed immediately if the exposure time was 4 hours.
Further reduction of the exposure time not only decreased the death rate but also altered the interval between exposure and death. Animals exposed for brief periods likewise die days after exposure (“late lethality”), which according to the Authors pointed to secondary cause of death not attributable to the primary toxicity of CTFE.
This variation occurs with increasing concentrations of CTFE after even short exposure.
All three stages of lethality occurred in some animals under the same conditions of concentration and time.
The complete set of lethality data are reproted in Table 1. - Clinical signs:
- other: no data
- Body weight:
- no data
- Gross pathology:
- no data
- Other findings:
- BIOCHEMICAL and MORPHOLOGICAL FINDINGS:
- Kidneys: After a brief exposure of only 1/2 hour to 0.3% concentration of CTFE the partes rectae of the main epithelium of the kidneys showed impaired histochemical ferment activity namely that of the glycerol-phosphate dehydrogenase according to Mellgren and Blackstadt method, fixation according to Conklin and of the succinate dehydrogenase according to Pearse method. The blood level of the isocitrate dehydrogenase activity rised early and rapidly. From these findings the authors concluded that CTFE damages primarily the mitochondria.
Subsequently a rapidly progressive necrotizing nephrosis ensued which leaded to uremia. The delayed lethality was concurrent with a sharp rise of the blood urea nitrogen, a fact which emphasizes the importance of damage to kidneys in CTFE poisoning. Animals which survived showed regeneration of the epitheliurn and scar formation in the kidneys. Simultaneously, the blood urea nitrogen, the ICDH content of the blood and the enzyme-histochemical findings becomed normal.
-Liver: Upon electronmicroscopic examination, the first visible changes in the liver are electron-dense deposits in the mitochondria which seemed to be calcium deposits. They disappeared during the recovery period. Additional damage to the liver was identical with that due to other hepatotoxic agents. They consisted of glycogen and RNA deterioration and fatty degeneration of parenchymal cell. Formation of large vacuoles in the parenchymal cells of the peripheral lobules was typical of CTFE. CTFE was not designated as a specific hepatotoxic agent because the relatively liver-specific sorbit-dehydrogenase was only slighyly elevated in serum.
- Heart: In the latter stages of poisoning, the myocardium exhibited necrosis
- Lungs : The lungs showed no damage except for capillary hypereznia and localized bleeding. More extensive pathology seemed to become manifest only with a high CTFE concentration (more than 0. 3%) or may be caused by agents accompanying CTFE. - Interpretation of results:
- Category 3 based on GHS criteria
- Conclusions:
- CTFE mainly impars kidney functionality. Damages on miocardium and liver were also observed.
Basing on the complete set of lethality, the LC50 (4h, mice) appears to be between 1000 ppmV and 3000 ppmV. - Executive summary:
In the Walther H.et al. (1970) study, mice were exposed to CTFE concentration in air of 0.1, 0.3 and 0.8 % v/v (1000, 3000, 8000 ppm v/v) for different exposure periods ranging in duration from 12 to 36 hours for the exposure level of 1000 ppm, from 2.5 to 16 hours for the exposure level of 3000 ppm, from 1 to 4.25 hours for the exposure level of 8000 ppm. Biochemical, optical, electron-microscopic and enzyme-histochemical examinations were made.
Basing on the results the authors distinguished three stages of lethality to CTFE: the immediate lethality (which was originally named by the authors “Acute lethality”) referred to lethality occurred during exposure, the “follow-up lethality”, referred to lethality which corresponded closely to the effects observed for acute lethality, “late lethality” indicating a marked interval between exposure to CTFE and death.
At the concentration of 1000 ppm, for an exposure period of 12 hours, the lethality (follow-up and delayed) of 40% was observed. Immediate lethality was observed when the exposure period was 16 hours, with a total lethality of 60% (immediate, follow-up and delayed)
At the concentration of 3000 ppm, for an exposure time of 4 hours, the lethality (immediate, follow-up and delayed lethality) of 85 % was observed.
At the concentration of 8000 ppm, for an exposure period of 2,5 hours the lethality of 100 % was observed (follow-up and delayed), when the exposure period was 4,25 hours 100 % of immediate lethality was reported.
Basing on the lethality results, the LC50 (mouse, 4h) appears to be between 1000 ppm and 3000 ppm.
At 3000 ppm, after 30 min of exposure, damage on kidney ephytelium was observed, attribyuted by the authors to damages on mitochondria (enzyme-histochemical findings + increasing of ICDH blood level). Then, a rapidly progressive necrotizing nephrosis was observed. Survival animals showed regeneration of ephythelium within 6 days, (scar formation in the kidney). Simultaneusly blood urea nitrogen, and enzyme-hystochemical findings become normal.
According to Walther Het al.,1970, the immediate and follow-up lethality of CTFE should be attributed to, generalized damage of mitochondria which affect kidneys, liver and myocardium. Necrosis of myocardium was observed in the latter stage of the poisoning. The "delayed" lethality was attributed to the prolonged and serious damage to kidneys.
Reference
TABLE 1.
Lethality data.
0.1% (v/v) CTFE | 0.3% (v/v) CTFE | 0.8% (v/v) CTFE | |||||||||
Exposure duration (hours) | Observation period (hours) | total lethality (%) |
Type of lethality | Exposure duration (hours) | Observation period (hours) | total lethality (%) |
Type of lethality | Exposure duration (hours) | Observation period (hours) | total lethality (%) |
Type of lethality |
36 | 36 | 100 | Immediate | 16 | 16 | 100 | Immediate | 4.25 | 4.25 | 100 | Immediate |
24 | 64 | 100 | Immediate + Follow-up | 7 | 16 | 100 | Immediate + Follow-up | 3 | 4.5 | 100 | Immediate + Follow-up |
16 | 144 | 60 | Immediate + Follow-up + Delayed |
4 | 144 | 85 | Immediate + Follow-up + Delayed |
2 | 6 | 100 | Immediate + Follow-up |
12 | 144 | 40 | Follow-up + Delayed |
2.5 | 144 | 30 | Follow-up + Delayed |
1.5 | 60 | 100 | Follow-up + Delayed |
1 | 144 | 75 | Follow-up + Delayed |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 11 580 mg/m³ air
- Quality of whole database:
- Three K2 studies and four K4 studies of acute toxicity by inhalation are available.
The key study for this endpoint was selected between the studies identified as K2, covering the range of exposure concentrations suitable for classification according to EU GHS criteria.
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
As the test substance is a gas at room temperature, studies through oral and dermal routes are not feasible.
Several studies (K2 or K4) through the inhalation route are available, performed on several species (rat, mouse, guinea pig, rabbit, dog). Basing on the results, the main target organ of CTFE is observed to be the kidney with first effects elicited in rats at concentrations above 102 ppm.
The key study (Walther et al.,1970) for this endpoint was selected between the studies having K2 reliability and covering the range of exposure concentrations (1000 to 8000 ppm) suitable for classification according to EU GHS criteria.
In this study the Authors distinguished three stages of lethality to CTFE: the immediate lethality, referred to lethality occurred during exposure, the“follow-up lethality”, referred to lethality which corresponded closely to the effects observed for acute lethality, the“delayed lethality”indicating a marked interval between exposure to CTFE and death. Biochemical, optical, electro-microscopic studies and enzyme-histochemical examinations, especially on the liver and kidneys were carried with the scope of establishing the different phases of the toxic sequence. According to Walther et al., 1970, the immediate and follow-up lethality of CTFE should be attributed to, generalized damage of mitochondria which affect kidneys, liver and myocardium. The“delayed”lethality was attributed to the prolonged and serious damage to kidneys.
In this study the LC50 (4h, mouse) was observed to be between 1000 and 3000 ppmV.
Other animal studies of lower reliability (K3 and K4) showed consistent range of toxicity in the mouse (LC50(4h,mouse) = 1758 ppm (Sakharova & Tolgskaya, 1977; Kennedy, 1990) and in other species:
LC50 (4h,rat M/F): 1000–4000 ppm (Hoodet al., 1956; Sakharova & Tolgskaya, 1977; Kennedy, 1990)
LC50 (4h, guinea pig): 903 ppm; (Sakharova & Tolgskaya, 1977; Kennedy, 1990)
LC50 (2h, rabbit) : 5040 ppm (Kennedy, 1990)
In Potteret al., 1981, (K2 reliability study), male rats were exposed 4 hours to 102, 222, 330, or 544 ppm CTFE concentrations.
No mortality was observed. Kidney damage (cellular necrosis of the proximal renal tubules localized in the pars recta within 24h following exposure; dose-related tubular necrosis, diuresis, increases in urinary fluoride, LDH activity, serum creatinine and BUN within two days following exposure) was reported for concentrations above 102 ppm (NOAEC = 102 ppm) and full recovery was observed within 2 weeks.
The Buckleyet al., 1982 study (K2 reliability) was designed to characterize the subacute nephrotoxicity of CTFE.
Male rats were exposed 4hours per day for 5 consecutive days or for a single exposure to 395 ppm of CTFE.
The results were consistent to what observed by Potteret al., 1981: the single or the short-term repeated exposure elicited nephrotoxicity with morphological changes reflecting injury to the proximal tubule and changes in the renal function.
Buckleyet al., 1982 also reported a rapid recovery and tolerance was observed, evidenced by similar changes in renal function of animals exposed once or for 5 days. There was a little increase in the severity of necrosis in animals exposed repeatedly after what appeared to be a maximum damage incurred after 3 days of exposure
Another study (Hood et al., 1956; K4 reliability study) reported transient leukopenia, persistent erythrocytosis, plasma cholesterol increase and encephalopathy in dogs receiving subacute exposure to rising concentration of CTFE (300 to 1000 ppm). Leukopenia, and changes in brain, spinal cord and nerves were also observed in one dog exposed to 1000 ppm of CTFE for a single 4h treatment. Anyway the validity of the findings reported by Hood et al.,1956 is questionable as the results were generated through an unsuitable test system, having significant methodological deficiencies and limited documentation on the test procedure.
Justification for classification or non-classification
CTFE is classified as Acute Toxicity by Inhalation Category 3 based on the LC50 (4h, mouse) > 1000 ppm; < 3000 ppm.
Kidney appears to be the target organ of CTFE and nephrotoxicity has been observed to be the main cause of the observed lethality. The effects observed on kidney at not lethal concentration are consistent with the effects observed at higher concentration which leaded mortality.
Being the effects on kidney the main cause of lethality at concentration which lead the classification in the hazard Class Acute toxicity Category 3 by Inhalation, the application of the hazard class STOT SE Category 1 (target organ: kidney) is considered unnecessary. In fact STOT-SE hazard class should be considered where there is clear evidence of toxicity to a specific organ, especially in the absence of lethality, and must be not applied for effects which are not yet lethal at a certain dose, but would lead to lethality within the numeric classification criteria.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.